Gilead Sciences (GILD)

63.68 +0.54 (0.86%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/25/19 *Est.)
- M&A (12/31/17 *Est)

Latest Headlines

UPDATE: Gilead Sciences (GILD), Galapagos NV (GLPG) Report EMA Validates Marketing Application for Filgotinib for Treatment of Rheumatoid Arthritis August 15, 2019 4:01 PM - StreetInsider EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS August 15, 2019 4:01 PM - StreetInsider European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis August 15, 2019 4:01 PM - BizWire Gilead Sciences (GILD) Underperforms Despite A Steady Stream Of Good News - Oppenheimer August 15, 2019 7:03 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Aug 10 Filed by: Pletcher Brett A August 13, 2019 6:48 PM - SEC Filing Gilead Sciences (GILD) Announces China National Medical Products Administration Approves Biktarvy for Treatment of HIV-1 Infection August 9, 2019 8:32 AM - StreetInsider China National Medical Products Administration Approves Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) for Treatment of HIV-1 Infection August 9, 2019 8:30 AM - BizWire Agenus (AGEN) Reports FDA Acceptance of IND Filing for AGEN2373 Triggers $7.5M Milestone Payment from Gilead Sciences Inc. (GILD) August 8, 2019 7:42 AM - StreetInsider Gilead Sciences (GILD) Statement on FDA Advisory Committee's Recommendation on Descovy for PrEP August 8, 2019 6:16 AM - StreetInsider Gilead Sciences Statement on U.S. Food and Drug Administration Advisory Committee’s Recommendation on Descovy for PrEP™ August 7, 2019 8:44 PM - BizWire Medicare to cover expensive cancer cell therapies August 7, 2019 5:37 PM - StreetInsider Gilead (GILD) Wins FDA Panel Backing for HIV Preventative Drug, Panel Voted 16 to 2 in Favor of Descovy - Bloomberg August 7, 2019 3:47 PM - StreetInsider Form 10-Q GILEAD SCIENCES INC For: Jun 30 August 6, 2019 4:27 PM - SEC Filing Popular stocks with increasing unusual volume: DIS V GILD FDX TEVA CHK August 6, 2019 11:19 AM - StreetInsider Ontario Provides Access to Biktarvy® for the Treatment of HIV August 6, 2019 8:00 AM - BizWire FDA Posts Briefing Document on Gilead Sciences's (GILD) Descovy Ahead of Meeting August 5, 2019 8:44 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $80 at Morgan Stanley August 1, 2019 8:44 AM - StreetInsider Gilead Sciences (GILD) PT Raised to $82 at BMO Capital July 31, 2019 7:35 AM - StreetInsider Gilead Sciences (GILD) Reports a Low Quality Beat/Raise, PT to $86 at Raymond James July 31, 2019 6:18 AM - StreetInsider Gilead Sciences (GILD) Declares $0.63 Quarterly Dividend; 3.8% Yield July 30, 2019 5:21 PM - StreetInsider Form 8-K GILEAD SCIENCES INC For: Jul 30 July 30, 2019 4:08 PM - SEC Filing Gilead Sciences (GILD) Tops Q2 EPS by 10c, Revises FY Guidance July 30, 2019 4:04 PM - StreetInsider Gilead Sciences Announces Third Quarter 2019 Dividend July 30, 2019 4:02 PM - BizWire Gilead Sciences Announces Second Quarter 2019 Financial Results July 30, 2019 4:01 PM - BizWire Gilead Sciences (GILD) option implied volatility bid up into EPS and outlook July 30, 2019 10:42 AM - StreetInsider Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments July 30, 2019 6:07 AM - StreetInsider Gilead Sciences (GILD) option implied volatility elevated into EPS and outlook July 29, 2019 10:54 AM - StreetInsider RBC Capital Upgrades Gilead Sciences (GILD) to Top Pick; 'Valuation Disconnect Too Big To Ignore' July 29, 2019 6:36 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jul 24 Filed by: Mercier Johanna July 26, 2019 5:41 PM - SEC Filing Gilead Sciences (GILD) traders bidding up IV into EPS and outlook July 26, 2019 10:49 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jul 23 Filed by: Pletcher Brett A July 25, 2019 6:38 PM - SEC Filing Gilead Sciences (GILD) Reports Latest Data in Ongoing HIV Cure Research Program July 23, 2019 4:00 PM - StreetInsider Gilead Announces Latest Data in Ongoing HIV Cure Research Program July 23, 2019 4:00 PM - BizWire Gilead Sciences (GILD) Presents New Findings on Profile of Descovy for Potential Use as HIV Pre-exposure Prophylaxis Compared With Truvada July 23, 2019 11:02 AM - StreetInsider Gilead Presents New Findings on Profile of Descovy® for Potential Use as HIV Pre-exposure Prophylaxis Compared With Truvada® July 23, 2019 11:00 AM - BizWire Gilead Sciences (GILD) Presents New Data on Biktarvy for Treatment of HIV in Women and in Virologically Suppressed Patients With Known Resistance July 22, 2019 12:01 PM - StreetInsider Gilead Presents New Data on Biktarvy® for the Treatment of HIV in Women and in Virologically Suppressed Patients With Known Resistance July 22, 2019 12:00 PM - BizWire Gilead Sciences (GILD) Presents Proof-of-Concept Data for GS-6207 in People with HIV July 22, 2019 11:01 AM - StreetInsider Gilead Presents Proof-of-Concept Data for GS-6207, a First-in-Class Capsid Inhibitor, in People Living With HIV July 22, 2019 11:00 AM - BizWire Pre-Open Movers 07/22: (SKIS) (DRRX) (DVA) Higher; (NTEC) (CALM) (PETS) (more...) July 22, 2019 9:28 AM - StreetInsider DURECT Corp (DRRX), Gilead (GILD) Enter into License Agreement for Long-Acting Injectable HIV Investigational Product July 22, 2019 8:01 AM - StreetInsider Gilead Sciences (GILD) Licenses Respiratory and Herpes Antiviral Research Programs From Novartis (NVS) July 19, 2019 8:31 AM - StreetInsider Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis July 19, 2019 8:30 AM - BizWire Form 8-K GILEAD SCIENCES INC For: Jul 14 July 18, 2019 11:46 AM - SEC Filing Gilead Sciences (GILD) to Present New Data on HIV Prevention, Treatment and Cure Research at IAS July 18, 2019 8:36 AM - StreetInsider Gilead to Present New Data on HIV Prevention, Treatment and Cure Research at IAS 2019 July 18, 2019 8:30 AM - BizWire Gilead Sciences (GILD) Should Acquire Otezla - RBC July 18, 2019 7:11 AM - StreetInsider Form 8-K GILEAD SCIENCES INC For: Jul 17 July 17, 2019 8:36 AM - SEC Filing Form 8-K GILEAD SCIENCES INC For: Jul 17 July 17, 2019 8:35 AM - SEC Filing Gilead Sciences (GILD) Announces Chief Scientific Officer John McHutchison to Leave Company July 17, 2019 8:33 AM - StreetInsider Gilead Sciences (GILD) Announces Gregg Alton, Chief Patient Officer, and Katie Watson, Executive Vice President, Human Resources, will be departing July 17, 2019 8:31 AM - StreetInsider Gilead Sciences’ Chief Scientific Officer John McHutchison to Leave the Company July 17, 2019 8:30 AM - BizWire Gilead Sciences Announces Changes to Senior Leadership Team July 17, 2019 8:30 AM - BizWire Gilead Sciences (GILD) Has Low Expectations Option In GLPG1690 - RBC Capital July 17, 2019 8:10 AM - StreetInsider Gilead Sciences to Release Second Quarter 2019 Financial Results on Tuesday, July 30, 2019 July 16, 2019 4:05 PM - BizWire Kite Announces Plans to Bolster Industry-Leading Cell Therapy Manufacturing Capabilities With New Viral Vector Facility July 16, 2019 8:30 AM - BizWire Pre-Open Movers 07/15: (GLPG) (CRZO) (NTGN) Higher; (SYMC) (CIR) (CPE) (more...) July 15, 2019 9:28 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $82 at Morgan Stanley July 15, 2019 8:55 AM - StreetInsider S&P ends near flat as Citigroup results sink banks; Nasdaq hits new high July 15, 2019 7:29 AM - StreetInsider Gilead Sciences (GILD) PT Lowered to $76 at BMO Capital July 15, 2019 7:16 AM - StreetInsider Gilead Sciences (GILD) PT Raised to $88 at Wells Fargo July 15, 2019 6:39 AM - StreetInsider Galapagos (GLPG) call put ratio 3 calls to 1 put into Gilead Sciences (GILD) $5.1B investment July 15, 2019 5:07 AM - StreetInsider Gilead Sciences (GILD) option implied volatility low into investing $5.1B in Galapagos (GLPG) July 15, 2019 5:05 AM - StreetInsider Wells Fargo Upgrades Gilead Sciences (GILD) to Outperform July 15, 2019 4:09 AM - StreetInsider Europe closes higher as upbeat China data boosts German shares July 15, 2019 4:04 AM - StreetInsider Gilead (GILD) Expands Collaboration with Galapagos (GLPG), Raises Stake to 22% July 14, 2019 4:13 PM - StreetInsider Gilead invests $5 billion to deepen ties with biotech Galapagos July 14, 2019 2:53 PM - StreetInsider GILEAD AND GALAPAGOS ENTER INTO TRANSFORMATIVE RESEARCH AND DEVELOPMENT COLLABORATION July 14, 2019 1:02 PM - StreetInsider GILEAD AND GALAPAGOS ENTER INTO TRANSFORMATIVE RESEARCH AND DEVELOPMENT COLLABORATION July 14, 2019 1:02 PM - StreetInsider Gilead and Galapagos Enter Into Transformative Research and Development Collaboration July 14, 2019 1:00 PM - BizWire Form CT ORDER GILEAD SCIENCES INC July 12, 2019 3:46 PM - SEC Filing Form CT ORDER GILEAD SCIENCES INC July 12, 2019 3:43 PM - SEC Filing Gilead Sciences (GILD) Could Outperform in 2H19 for 4 Reasons July 12, 2019 8:22 AM - StreetInsider Gilead Sciences (GILD) Appoints Christi L. Shaw as CEO of Kite July 11, 2019 4:31 PM - StreetInsider Gilead Appoints Christi L. Shaw as Chief Executive Officer of Kite July 11, 2019 4:30 PM - BizWire Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH) July 11, 2019 8:30 AM - BizWire Form 3 GILEAD SCIENCES INC For: Jul 01 Filed by: Mercier Johanna July 10, 2019 5:12 PM - SEC Filing Gilead Sciences (GILD) Hits Session Low, Down 3% July 8, 2019 2:18 PM - StreetInsider RBC Provides 8 Reasons to Buy Gilead Sciences (GILD) July 3, 2019 10:24 AM - StreetInsider Gilead Sciences (GILD) to Submit Filgotinib NDA This Year July 2, 2019 6:42 AM - StreetInsider Tariff threats on EU goods do little to curb gains in European shares July 2, 2019 3:38 AM - StreetInsider GILEAD ANNOUNCES INTENT TO SUBMIT NEW DRUG APPLICATION FOR FILGOTINIB TO U.S. FOOD AND DRUG ADMINISTRATION THIS YEAR July 2, 2019 1:03 AM - StreetInsider GILEAD ANNOUNCES INTENT TO SUBMIT NEW DRUG APPLICATION FOR FILGOTINIB TO U.S. FOOD AND DRUG ADMINISTRATION THIS YEAR July 2, 2019 1:02 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jun 27 Filed by: Lofton Kevin E July 1, 2019 7:48 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: Jun 27 Filed by: Lofton Kevin E July 1, 2019 7:43 PM - SEC Filing Form 4 GILEAD SCIENCES INC For: Jun 27 Filed by: Whitley Richard James July 1, 2019 7:40 PM - SEC Filing Gilead Announces Intent to Submit New Drug Application for Filgotinib to U.S. Food and Drug Administration This Year July 1, 2019 7:00 PM - BizWire Louisiana Launches Hepatitis C Innovative Payment Model With Asegua Therapeutics, Aiming to Eliminate the Disease June 26, 2019 11:30 AM - BizWire Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies June 24, 2019 7:00 PM - BizWire Gilead Sciences (GILD) Threat Appears From Merck - RBC June 21, 2019 8:55 AM - StreetInsider Form 4 GILEAD SCIENCES INC For: Jun 18 Filed by: Pletcher Brett A June 20, 2019 4:53 PM - SEC Filing Gilead (GILD), Nurix Announce Pact to Develop Novel Therapies for Cancer and Other Diseases June 19, 2019 8:31 AM - StreetInsider Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases June 19, 2019 8:30 AM - Globe NewsWire Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases June 19, 2019 8:30 AM - BizWire GT Biopharma Company Update June 10, 2019 7:30 AM - PR NewsWire Form CT ORDER GILEAD SCIENCES INC June 7, 2019 12:46 PM - SEC Filing Kite Announces New Yescarta® Data From ZUMA-1 June 3, 2019 9:00 AM - BizWire Gilead Sciences (GILD) Subsidiary Kite Reports End of Phase 1 ZUMA-3 Results for KTE-X19 at ASCO 2019 Meetings June 3, 2019 5:52 AM - StreetInsider Kite Announces End of Phase 1 ZUMA-3 Results for KTE-X19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia June 1, 2019 6:00 PM - BizWire Kite (GILD) and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta With lenzilumab in R/R DLBCL May 31, 2019 8:32 AM - StreetInsider Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta® (axicabtagene ciloleucel) With lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma May 31, 2019 8:32 AM - StreetInsider Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta® (axicabtagene ciloleucel) With lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma May 31, 2019 8:31 AM - Globe NewsWire Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta® (Axicabtagene Ciloleucel) with Lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma May 31, 2019 8:30 AM - BizWire Gilead Sciences (GILD) 30-day option implied volatility is at 25; compared to its 52-week range of 19 to 43 into ASCO May 30, 2019 6:29 AM - StreetInsider Gilead Sciences (GILD) and Galapagos (GLPG) to Present Latest Data on Filgotinib at EULAR May 29, 2019 4:34 PM - StreetInsider GILEAD AND GALAPAGOS TO PRESENT LATEST DATA ON FILGOTINIB AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY (EULAR 2019) May 29, 2019 4:32 PM - StreetInsider GILEAD AND GALAPAGOS TO PRESENT LATEST DATA ON FILGOTINIB AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY (EULAR 2019) May 29, 2019 4:31 PM - StreetInsider Gilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019) May 29, 2019 4:30 PM - BizWire Form 8-K GILEAD SCIENCES INC For: May 23 May 29, 2019 8:42 AM - SEC Filing Gilead Sciences Appoints Johanna Mercier as Chief Commercial Officer May 29, 2019 8:31 AM - BizWire Gilead Sciences (GILD) option implied volatility flat into ASCO May 29, 2019 5:55 AM - StreetInsider Pre-Open Movers 05/28: (JMEI) (PLAN) (TSS) Higher; (GPN) (NTNX) (GILD) (more...) May 28, 2019 9:29 AM - StreetInsider Goldman Sachs Downgrades Gilead Sciences (GILD) to Sell May 28, 2019 2:21 AM - StreetInsider Gilead Sciences (GILD) call put ratio 3.6 calls to 1 put with focus on June calls May 23, 2019 10:58 AM - StreetInsider Citi Upgrades Gilead Sciences (GILD) to Buy May 23, 2019 4:19 AM - StreetInsider Citi Upgrades Gilead Sciences (GILD) to Buy May 22, 2019 5:22 PM - StreetInsider Gilead Sciences to Present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5 May 21, 2019 4:01 PM - BizWire Gilead Sciences (GILD) PT Raised to $79 at SVB Leerink May 21, 2019 7:32 AM - StreetInsider Full Article List